The Oxford-AstraZeneca vaccine is best suited for Africa according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi.
Professor Madhi is leading the clinical trial of the vaccine locally.
He said the vaccine isn’t only effective but also affordable.
The Oxford vaccine is so far reported to have a good safety record with no serious side-effects.
The ongoing late-stage trial is taking place at 150 global sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.
More Stories
Mogoeng Mogoeng Ordered To Apologise For Israel Comments
Best results in history of NSC – Motshekga
Basic Education Dept Hopes For Return To Full Capacity
NICD Reports 3 962 New COVID-19 Cases In SA
State Was Hijacked Through Cadre Deployment – Madonsela
SAA To Resume Johannesburg-Durban Flights In March
Unemployment Crisis Not Due To Foreigners – Amnesty International
NICD Reports 4 322 New COVID-19 Cases In SA
University Fee Hikes On The Cards
Western Cape Education Dept Ready To Welcome Back Pupils
Transport Department To Appeal AARTO Court Ruling
NICD Reports 1 691 New COVID-19 Cases In SA